Ignite Creation Date:
2025-12-24 @ 10:57 PM
Ignite Modification Date:
2026-02-20 @ 10:10 PM
Study NCT ID:
NCT03946969
Status:
UNKNOWN
Last Update Posted:
2022-07-19
First Post:
2019-05-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sintilimab in Combination With Chemotherapy in Neoadjuvant Treatment of Potentially Resectable Esophageal Cancer
Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05-09
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-10-31
Completion Date Type:
ESTIMATED
First Submit Date:
2019-05-09
First Submit QC Date:
None
Study First Post Date:
2019-05-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-07-16
Last Update Post Date:
2022-07-19
Last Update Post Date Type:
ACTUAL